KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Short-term Investments (2016 - 2025)

Humana (HUM) has disclosed Short-term Investments for 14 consecutive years, with $15.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Short-term Investments changed N/A to $15.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $15.7 billion, a N/A change, with the full-year FY2025 number at $15.7 billion, changed N/A from a year prior.
  • Short-term Investments was $15.7 billion for Q4 2025 at Humana, down from $16.7 billion in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $17.9 billion in Q1 2025 to a low of $13.0 billion in Q2 2022.
  • A 3-year average of $14.6 billion and a median of $13.6 billion in 2021 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: rose 19.34% in 2021, then decreased 4.34% in 2022.
  • Humana's Short-term Investments stood at $13.2 billion in 2021, then rose by 5.22% to $13.9 billion in 2022, then grew by 13.13% to $15.7 billion in 2025.
  • Per Business Quant, the three most recent readings for HUM's Short-term Investments are $15.7 billion (Q4 2025), $16.7 billion (Q3 2025), and $17.7 billion (Q2 2025).